Longevica Pharmaceuticals, Inc., is a biotechnology company that is developing drugs with potential use in the treatment of cancer, degenerative diseases and age-related disorders. The company was formed primarily to commercialize the discoveries demonstrating that inactivation of an alpha kinase, EF2 kinase, aims to p...
More >>Longevica Pharmaceuticals, Inc., is a biotechnology company that is developing drugs with potential use in the treatment of cancer, degenerative diseases and age-related disorders. The company was formed primarily to commercialize the discoveries demonstrating that inactivation of an alpha kinase, EF2 kinase, aims to protect normal (non-cancer) cells and tissues from the toxic effect of chemotherapy or radiation treatments.nDespite the tremendous progress in drug cancer chemotherapy, most of the drugs used today have a pronounced toxicity effect, killing normal cells along with cancer cells. The work being done by scientists at Longevica may lead to a approach in cancer therapy that can improve the efficiency of the current methods of cancer treatment.nThe discoveries are also expected to be helpful in treating patients suffering from ischemia, stroke and neurodegenerative disorders such as Alzheimer's disease by protecting cells and tissues from stress damage.
<< Less
